首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1935317

按產品類型、最終用戶和地區分類的藥品追溯市場

Pharmaceutical Traceability Market, By Product Type, By End User, By Geography

出版日期: 2026年01月13日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，藥品追溯市場規模將達到 74.2 億美元，到 2033 年將達到 225 億美元，2026 年至 2033 年的複合年成長率為 18.4%。

報告內容		報告詳情
基準年：	2025	2026年市場規模：	74.2億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	18.40%	2033 年的預測值：	225億美元

藥品溯源市場提供各種技術和解決方案，能夠追蹤和檢驗藥品在整個供應鏈中的流向。透過監控藥品從生產商到經銷商、藥局和醫療機構的流轉，這些溯源系統可以驗證產品真偽，防止假冒偽劣產品，並保障病人安全。序列化、條碼、RFID標籤和基於區塊鏈的追蹤等解決方案，有助於企業維持透明度、遵守法規並提高營運效率。

對假藥日益成長的擔憂、政府嚴格的監管以及對安全供應鏈不斷成長的需求，正促使企業採用藥品追溯解決方案。雲端平台、即時監控以及與業務線計劃 (ERP) 系統的整合等技術進步，提高了供應鏈的透明度並簡化了營運。隨著製藥公司、經銷商和醫療服務提供者越來越重視安全性、課責和合規性，對追溯解決方案的需求也在不斷成長，這推動了創新，並確保向全球患者持續提供正品藥品。

市場動態

藥品追溯市場成長的主要原因是打擊假藥和保障病人安全的需求日益成長。假冒偽劣藥品對公眾健康構成威脅，促使各國政府和醫療機構加強監管並實施藥品追溯要求。製藥公司正積極採用追溯解決方案，以遵守藥品序列化法規、維護產品完整性並保護品牌聲譽。整個藥品供應鏈對品質保證和風險管理的日益重視，推動了對先進追溯技術的需求。

技術創新正在顯著改變市場動態。企業正利用序列化、條碼、RFID標籤和區塊鏈解決方案來提升供應鏈的透明度和營運效率。將這些解決方案與雲端平台、即時監控和業務線計劃（ERP）系統整合，使相關人員能夠無縫追蹤產品從生產到最終用戶的整個過程。這些創新正在簡化物流、提高數據準確性、增強可追溯性並確保合規性，從而使供應鏈更加透明和穩健。

不斷擴大的醫療基礎設施和日益成長的全球藥品貿易進一步推動了市場成長。隨著製造商、經銷商和醫療服務提供者將安全且有效率的供應鏈放在首位，可追溯性解決方案的採用正在加速。消費者對藥品安全性和品質意識的提升也是推動其應用的重要因素。各公司正透過開展教育宣傳活動和培訓計畫來確保正確實施。這些因素共同作用，推動創新，加強監管合規，並促進全球藥品可追溯性市場的擴張。

本次調查的主要特點

本報告對藥品可追溯性市場進行了詳細分析，以 2025 年為基準年，給出了預測期（2026-2033 年）內的市場規模（十億美元）和復合年成長率（%）。
我們也將重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
該報告根據以下參數對醫藥溯源市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本報告的研究結果將使負責人和企業經營團隊能夠就即將推出的產品、類型升級、市場擴張和行銷策略做出明智的決策。
這份藥品可追溯性市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員將能夠透過用於分析藥品追溯市場的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第7章競爭情勢

熱圖分析
市佔率分析（3x3矩陣）
公司簡介
- Optel Ltd.
- The Healthcare Distribution Alliance（HDA）Inc.
- Bureau Veritas
- Adents
- Logista Pharma
- rfxcel Corporation
- Movilitas Consulting AG
- Trace Link Inc.
- Avery Dennison Corporation
- Pharmalutions Pte Ltd.
- Cognex Corporation

第8章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第9章各節

參考
調查方法

簡介目錄

Product Code: CMI4490

Pharmaceutical Traceability Market is estimated to be valued at USD 7.42 Bn in 2026 and is expected to reach USD 22.5 Bn by 2033, growing at a compound annual growth rate (CAGR) of 18.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 7.42 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	18.40%	2033 Value Projection:	USD 22.5 Bn

The Pharmaceutical Traceability Market delivers technologies and solutions that allow stakeholders to track and verify pharmaceutical products throughout the supply chain. By monitoring the movement of drugs from manufacturers to distributors, pharmacies, and healthcare providers, these traceability systems confirm product authenticity, prevent counterfeiting, and protect patient safety. Solutions such as serialization, barcoding, RFID tagging, and blockchain-based tracking help companies maintain transparency, comply with regulations, and improve operational efficiency.

Growing concerns over counterfeit medicines, strict government regulations, and increasing demand for secure supply chains are driving companies to adopt pharmaceutical traceability solutions. Advancements in technology, including cloud-based platforms, real-time monitoring, and integration with enterprise resource planning (ERP) systems, enhance supply chain visibility and streamline operations. As pharmaceutical manufacturers, distributors, and healthcare providers focus more on safety, accountability, and compliance, the demand for traceability solutions expands, fostering innovation and ensuring the consistent delivery of authentic medicines to patients worldwide.

Market Dynamics

The Pharmaceutical Traceability Market grows mainly due to the increasing need to combat counterfeit drugs and protect patient safety. Counterfeit and substandard medicines threaten public health, prompting governments and healthcare organizations to enforce stricter regulations and tracking mandates. Pharmaceutical companies actively adopt traceability solutions to comply with serialization laws, preserve product integrity, and safeguard their brand reputation. This heightened focus on quality assurance and risk management across the drug supply chain drives demand for advanced tracking technologies.

Technological innovation significantly shapes market dynamics. Companies employ serialization, barcoding, RFID tagging, and blockchain-based solutions to enhance supply chain visibility and operational efficiency. By integrating these solutions with cloud-based platforms, real-time monitoring, and enterprise resource planning (ERP) systems, stakeholders can track products seamlessly from manufacturing to end-users. These innovations streamline logistics, improve data accuracy, strengthen traceability, and ensure regulatory compliance, making supply chains more transparent and resilient.

Expanding healthcare infrastructure and growing global pharmaceutical trade further support market growth. As manufacturers, distributors, and healthcare providers prioritize secure and efficient supply chains, they increasingly adopt traceability solutions. Rising consumer awareness about drug safety and quality also boosts adoption. Companies complement this with educational campaigns and training programs to ensure proper implementation. Together, these factors drive innovation, enhance regulatory adherence, and promote the global expansion of the pharmaceutical traceability market.

Key Features of the Study

This report provides in-depth analysis of the Pharmaceutical Traceability Market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Pharmaceutical Traceability Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Optel Ltd., The Healthcare Distribution Alliance (HDA) Inc., Bureau Veritas, Adents, Logista Pharma, rfxcel Corporation, Movilitas Consulting AG, Trace Link Inc., Avery Dennison Corporation, Pharmalutions Pte Ltd. and Cognex Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Pharmaceutical Traceability Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Pharmaceutical Traceability Market

Market Segmentation

By Product Type (Revenue, USD Bn, 2026 - 2033)
- Barcode
- Radio Frequency Identification (RFID)
- Global Positioning System (GPS)
- Others
By End User (Revenue, USD Bn, 2026 - 2033)
- Hospitals
- Pharmacies
- Pharmaceutical Factories
- Others
By Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Optel Ltd.
- The Healthcare Distribution Alliance (HDA) Inc.
- Bureau Veritas
- Adents
- Logista Pharma
- rfxcel Corporation
- Movilitas Consulting AG
- Trace Link Inc.
- Avery Dennison Corporation
- Pharmalutions Pte Ltd.
- Cognex Corporation.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Pharmaceutical Traceability Market, By Product Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Barcode
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Radio Frequency Identification (RFID)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Global Positioning System (GPS)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Pharmaceutical Traceability Market, By End User, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pharmaceutical Factories
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Pharmaceutical Traceability Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- Optel Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- The Healthcare Distribution Alliance (HDA) Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Bureau Veritas
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Adents
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Logista Pharma
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- rfxcel Corporation
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Movilitas Consulting AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Trace Link Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Avery Dennison Corporation
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Pharmalutions Pte Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Cognex Corporation
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates